Danaher Extends Offer for Beckman Coulter | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher announced late on Tuesday that it has extended its offer to buy Beckman Coulter to expire at midnight EDT April 27.

The offer had been set to expire at midnight EDT today. All other terms and conditions of Danaher's $6.8 billion bid for Beckman Coulter are unchanged.

The deal is expected to close during the second quarter, Danaher said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.